About PharOS
PharOS was established in 2002 in Metamorfosi, Greece, as a manufacturer and supplier within the pharmaceutical sector. Operations focus on the production and distribution of generic drugs, serving markets through established supply chains. The company is led by co-founder Stella Koukaki, with activities centered in Greece and supported by the domain pharosgr.gr for online presence. Core services include formulation, quality control, and regulatory compliance for generic medications.
- Headquarter Metamorfosi, Greece
- Founders Stella Koukaki
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharosgr.gr
- Social LinkedIn X
- Investors
Funding Insights of PharOS
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of PharOS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | – | Private Equity Round | – | DECA Investments | – |
1 investors in total: 1 institutional.
Investors in PharOS
PharOS has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include DECA Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are directed toward SMEs in Greece. | – | decainvestments.eu | Athens, Greece |
Investor details for PharOS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PharOS
9 people are tracked at PharOS (3 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Stella Koukaki | Co-Founder | Leadership |
Panagiotis Panagopoulos | R&d Director, Managing Partner | Leadership |
Nadia Gialou | Scientific Affairs Associate Director | Leadership |
Alda Angela Vella | Regulatory Affairs Specialist | Team |
Ersilia Naselli | Regulatory Affairs Specialist | Team |
Pandora Alexaki | Product Development Manager | Team |
Elissavet Theodorou | Regulatory Affairs Project Manager | Team |
George Vachratidis | Product Development Senior Supervisor | Team |
Evangelia Athanasoula | Product Development Specialist | Team |
Complete people profiles for PharOS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PharOS
2 dated milestones of PharOS across 17 years, from founding to its latest funding, stage changes and deals.
- Founded PharOS is founded.
- Funding First funding round.
Web traffic of PharOS
The website of PharOS (pharosgr.gr) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 69.1% vs previous month
Websites whose visitors overlap most with PharOS. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
acronym.gr | acronym.gr | 100% | – | – | – |
icap.gr | icap.gr | 100% | – | #11,370,400 | – |
methexis-consult.gr | methexis-consult.gr | 100% | – | – | – |
elyros.com | elyros.com | 100% | – | – | – |
spin-communications.com | spin-communications.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for PharOS
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to PharOS
10 companies that operate in the same segment as PharOS (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PharOS
PharOS was founded in 2002 and raised its 1st funding round 17 years after it was founded.
PharOS is headquartered in Metamorfosi, Greece. It is registered at Metamorfosi, Attica, Greece.
PharOS was established in 2002 in Metamorfosi, Greece, as a manufacturer and supplier within the pharmaceutical sector. Operations focus on the production and distribution of generic drugs, serving markets through established supply chains. The company is led by co-founder Stella Koukaki, with activities centered in Greece and supported by the domain pharosgr.gr for online presence. Core services include formulation, quality control, and regulatory compliance for generic medications.
PharOS has 1 investor. Key investors include DECA Investments.